P/E at 59.81 vs Industry's 58.40: What the Data Shows for Apollo Hospitals Enterprise Ltd.

2 hours ago
share
Share Via
Apollo Hospitals Enterprise Ltd continues to consolidate its stature as a key constituent of the Nifty 50 index, reflecting robust institutional confidence and outperforming broader market benchmarks. With a recent upgrade to a Buy rating and sustained large-cap status, the hospital sector heavyweight demonstrates resilience and growth potential amid evolving market dynamics.

Valuation Picture: Slight Premium in a Large-Cap Hospital Stock

The current P/E of 59.81 for Apollo Hospitals Enterprise Ltd. sits just above the industry average of 58.40, indicating investors are willing to pay a modest premium for its earnings relative to peers. This premium, while not excessive, suggests confidence in the company’s earnings quality and growth prospects within the hospital sector. The market capitalisation stands at a substantial ₹1,08,716.30 crores, underscoring its status as a large-cap stock within the healthcare space.

This valuation context is important — Apollo Hospitals is not trading at a steep premium that would typically raise concerns about overvaluation, but the slight elevation above sector norms invites scrutiny of its recent performance and technical positioning. Previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in this valuation premium alongside other metrics.

Performance Across Timeframes: Mixed Momentum Signals

Examining returns across multiple periods reveals a complex performance profile. Over the past year, Apollo Hospitals has delivered a 7.02% gain, outperforming the Sensex’s slight decline of -0.57%. This outperformance extends to longer horizons, with three-year returns at 72.26%, five-year returns at 147.08%, and an impressive ten-year return of 461.03%, all significantly ahead of the Sensex’s respective 30.38%, 59.95%, and 204.79% gains.

However, the short-term momentum is more subdued. The one-month return of 0.77% lags behind the Sensex’s 2.68%, and the one-week gain of 0.62% is slightly below the Sensex’s 0.72%. The three-month return of 4.49% is positive but modest, especially when contrasted with the Sensex’s sharper decline of -6.54%. This divergence suggests that while the stock has demonstrated resilience relative to the broader market, its short-term momentum is less robust than the index’s recent recovery. Is this a recovery or a dead-cat bounce? — the moving average configuration provides the clearest answer.

Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.

  • - New Reliable Performer
  • - Steady quarterly gains
  • - Fertilizers consistency

Discover the Steady Winner →

Moving Average Configuration: Bullish Across All Key Averages

Technically, Apollo Hospitals is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This comprehensive positioning above all major moving averages indicates a strong upward trend and suggests that recent price action is supported by sustained buying interest. Such a configuration is often interpreted as a bullish signal, reflecting positive momentum across both short and long-term horizons.

This technical strength contrasts with the more muted short-term returns, implying that the stock may be consolidating gains or preparing for further advances. Is this technical setup signalling a trend continuation or a pause before a correction? The data points to a resilient trend, but investors should monitor volume and broader sector dynamics for confirmation.

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced mixed results recently, with some companies reporting flat or negative returns amid evolving healthcare demand and regulatory pressures. Within this environment, Apollo Hospitals stands out with its consistent outperformance over multiple timeframes. The sector’s average P/E of 58.40 reflects moderate valuation levels, and Apollo’s slight premium suggests a degree of investor confidence in its operational execution and market positioning.

Sector results have been varied, with some companies struggling to maintain growth momentum. Against this backdrop, Apollo Hospitals’s ability to sustain positive returns and maintain a strong technical profile is noteworthy. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Get the full story on Apollo Hospitals Enterprise Ltd.! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this Hospital large-cap. Make informed decisions!

  • - Full research story
  • - Sector comparison done
  • - Informed decision support

View Detailed Report →

Rating Context: Previously Hold, Now Reassessed

On 13 Apr 2026, Apollo Hospitals Enterprise Ltd. had its rating updated from Hold, reflecting a reassessment of its fundamentals, valuation, and technicals. The previous Mojo Score stood at 75.0, indicating a solid standing within its sector. This rating change aligns with the company’s consistent outperformance relative to the Sensex and its strong technical positioning.

The reassessment takes into account the stock’s premium valuation, steady long-term returns, and bullish moving average configuration. What is the current rating for Apollo Hospitals, and how should investors interpret this update?

Conclusion: Data Reflects a Balanced Yet Positive Outlook

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a modest premium to its sector, supported by strong long-term returns and a robust technical setup. While short-term momentum shows some moderation, the stock’s position above all major moving averages suggests underlying strength.

Its performance relative to the Sensex across multiple timeframes, combined with a recent rating reassessment from Hold, indicates that the company remains a significant player within the hospital sector. The valuation premium is justified by consistent earnings growth and market leadership, but investors should remain attentive to sector trends and short-term price action. Is now the time to hold, accumulate, or reconsider your position in Apollo Hospitals?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News